Product Information
CROMOLYN SODIUM NASAL SPRAY is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.2477 per ML under NDC 57782039726. Its NADAC has been published 514 times since Nov 28, 2013.
FDA first approved this application on Jul 3, 2001.
Strength
5.2 mg/1
Manufacturer
Bausch & Lomb IncorporatedNDC
57782039726
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/17/2025
Active Ingredients
CROMOLYN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA075702FDA Approved
7/3/2001
On Market Since
7/3/2001
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN SODIUM NASAL SPRAY has been published 514 times since Nov 28, 2013, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2477 per ML |
|---|---|
| All-time high | $0.3347 (Jul 10, 2019) |
| All-time low | $0.1993 (Jul 17, 2024) |
| Median price | $0.2626 |
| Average price | $0.2643 |
| Largest weekly change | +26.9% (Aug 21, 2024) |
| Weeks tracked | 514 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+0.4%
5Y
-7.3%
All
-2.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cromolyn Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cromolyn Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN SODIUM NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN SODIUM NASAL SPRAY, manufactured by Bausch & Lomb Incorporated, is $0.2477 per ML (NDC 57782039726), effective Oct 1, 2025.
How has the price of CROMOLYN SODIUM NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for CROMOLYN SODIUM NASAL SPRAY has declined 2.3%. It has been tracked across 514 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CROMOLYN SODIUM NASAL SPRAY?
Since Nov 28, 2013, the NADAC for CROMOLYN SODIUM NASAL SPRAY has ranged from a low of $0.1993 (Jul 17, 2024) to a high of $0.3347 (Jul 10, 2019), with a median of $0.2626 per ML.
Are there cheaper alternatives to CROMOLYN SODIUM NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN SODIUM NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CROMOLYN SODIUM NASAL SPRAY?
CROMOLYN SODIUM NASAL SPRAY (NDC 57782039726) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.